Primary surgical treatment is associated with improved survival for patients with stage IV disease and specifically T4 primary tumors. These data suggest that the observed national decrease in survival from laryngeal cancer may be due to a shift toward nonoperative treatment in that subset of patients with advanced primary disease.

A method of film dosimetry for high energy photon beams is proposed which reduces the required film calibration exposures to a set of films obtained for a small radiation field size and shallow depth (6 cm x 6 cm at 5 cm depth). It involves modification of a compression type polystyrene film phantom to include thin lead foils parallel to the vertical film plane at approximately 1 cm from both sides of the film emulsion. The foils act as high atomic number filters which remove low energy Compton scatter photons that otherwise would cause the film sensitivity to change with field size and depth. The proposed method is best described as "lateral scatter filtering." To validate the proposed method, central axis depth doses and isodose curves for a 4 MV photon beam were determined from films exposed within the modified phantom and the results compared with ionization chamber measurements. When no lateral filtering was used, for field sizes of 6 cm x 6 cm and 25 cm x 25 cm, this comparison demonstrated up to a 65% difference between film and ionization chamber central axis depth dose measurements. When using the lateral scatter filtering technique, less than a 4% difference was observed for these field sizes.

There is a high incidence of occult metastases in clinically node-negative patients which adversely affects survival, regardless of the use of adjuvant XRT. Postoperative XRT did not significantly affect regional control or survival rates in patients with <3 positive nodes. When ECS was present, survival was poor regardless of the number of nodes. These data emphasize the prognostic and therapeutic role of END and highlight the need for the development of novel therapeutic regimens to improve disease control and survival in HNSCC patients with nodal metastases.

Object Stereotactic radiosurgery (SRS) with the Gamma Knife (GK) is a rapidly emerging surgical modality in the management of medically refractory idiopathic trigeminal neuralgia (TN). The current study examines the long-term outcome in patients with drug-resistant idiopathic TN who underwent GK surgery at the authors‘ institution. Methods One hundred and six consecutive patients (38 men and 68 women) with proven medically refractory idiopathic TN were included in this retrospective study. Their ages were 41–82 years (mean 72.3 years). All patients underwent SRS with prescribed maximal radiation doses ranging from 70 to 85 Gy. Isocenters 1–3 were used and plugging was used selectively. The follow-up period was 12–72 months (mean 34.3 months). The patients were divided into 2 groups according to their history of previous surgery. Results The initial response rate in patients with no history of previous surgery was 92.9%; in those who had undergone previous surgery, the initial response rate was 85.7%. At the end of the 1st posttreatment year, an excellent outcome was achieved in 82.5% of patients who had not had previous surgery, and in 69.4% of those who had. The respective outcome rates for the 2nd posttreatment year were 78 and 63.5%, respectively. The most common complication was the development of persistent paresthesia, which occurred in 15.8% of patients with no previous surgery and 16.3% of those with previous surgery. Conclusions Stereotactic radiosurgery with the GK is a safe and effective treatment option for patients with medically refractory idiopathic TN.

No abstract